- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05106673
Clinical Implementation and Evaluation for the Family-oriented Care CHIMPS-NET (Ci-Chimps)
Clinical Implementation and Evaluation of Three Implementation Interventions for a Family-oriented Care for Children of Mentally Ill Parents (Ci-CHIMPS)
Study Overview
Status
Conditions
Detailed Description
A two-group randomized controlled multicenter trial will examine changes in family-oriented practice and aspects of implementation at baseline as well as at 12- and 24-months follow-up. The CHIMPS-Network consists of twenty clinical centers. The centers in the intervention group receive the support of all of the three implementation interventions: 1) Optimal pathways to care 2) Education and a training program for professionals and 3) Systematic screening for children. The centers in the control group do not get this specific implementation support.
The implementation of all the CHIMPS interventions refers to and builds on a theoretical model developed by researchers from Australia and Norway, adapted to the German care system setting including adult psychiatry and child and adolescent psychiatry.
In ci-CHIMPS we aim to determine if three implementation interventions are helpful in improving the clinical implementation of the CHIMPS-NET interventions. Additionally, we want to identify factors hindering or promoting implementation processes. In order to monitor the impact of the three implementation interventions we will use the translated version of the "Family Focused Mental Health Practice Questionnaire (FFMHPQ)" (Laser et al., 2019, in prep.) and the translated version of the "Implementation Components Questionnaire (ICQ)" (Laser, Skogøy, Maybery & Wiegand-Grefe, 2019. in prep). The introduction of these questionnaires in Germany has not yet been reported.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Silke Wiegand-Grefe, Prof. Dr.
- Phone Number: 0049-40-7410-53603
- Email: silke.wiegand-grefe@uke.de
Study Locations
-
-
-
Hamburg, Germany, 20251
- Recruiting
- Universitatsklinikum Hamburg Eppendorf
-
Contact:
- Silke Wiegand-Grefe, Prof. Dr.
- Phone Number: 0049-40-7410-53603
- Email: silke.wiegand-grefe@uke.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Every employee, which is involved in the treatment of the patients (Medicine, Psychology, Nurses) of every clinical center that is part of the CHIMPS-NET project will be invited to participate in this study ci-CHIMPS.
Exclusion Criteria:
- There are no explicit criteria for exclusion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: clinical centers that receive implementation support
These clinical centers receive support during the implementation of the CHIMPS-intervention.
There are three different implementation interventions.
|
The first implementation measure focuses on optimal ways of caring for mentally ill patients who are also parents with children living in the household.
The main goals of this intervention are the specific information of the referring physician, the indicated referral of mentally ill parents and the consideration of underage children living in the household in the inpatient referral.
The two main components are the evaluation of the attitudes of the medical and psychotherapeutic referrers towards the target group and the intervention as well as the development and implementation of an optimal care pathway.
The optimization of the allocation is organized by Silke Pawils (University Medical Center Hamburg-Eppendorf).
The second implementation intervention concerns the improvement of the professionals' attitudes, knowledge and skills.
The two main components here being the assessment of the current state in all institutions within the clinical centers and the development and implementation of an education and training program.
The employees of the randomized clinical centers in the intervention group will get a three-hour training.
This intervention is organized by Svenja Taubner (University Hospital Heidelberg, Germany).
The third implementation intervention includes a systematic screening process to improve detection of mentally ill parents with affected children.
Employees of the clinical centers fill out two short questionnaires with the parents.
This intervention project is organized by Sibylle M. Winter (Charité, Berlin, Germany).
|
Experimental: No Intervention: Treatment as usual
These clinical centers will be the control group and will not get a specific implementation support during the implementation of CHIMPS.
|
No Intervention: Treatment as usual These clinical centers will be the control group and will not get a specific implementation support during the implementation of CHIMPS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Family Focused Mental Health Practice Questionnaire (FFMHPQ)
Time Frame: Change from baseline of the study at 12- and 24-months follow-up
|
Measures numerous aspects relevant for family-oriented practice from the employee's point of view with the translated version of the 'Family Focused Mental Health Practice Questionnaire (FFMHPQ)'.
(Laser C, Reupert A, Wiegand-Grefe S, Maybery D. Fragebogen zur familienorientierten Arbeit im psychosozialen Gesundheitswesen - deutsche Übersetzung des "Family Focused Mental Health Practice" von Maybery, Goodyear & Reupert.
2019.
(in prep.)
|
Change from baseline of the study at 12- and 24-months follow-up
|
Implementation Components Questionnaire (ICQ-35)
Time Frame: Change from baseline of the study at 12- and 24-months follow-up
|
Measures from the employee's point of view their perceived level of integration of the intervention within their clinical center.
It determines special components of implementation with the translated version of the 'Implementation Components Questionnaire (ICQ-35)'.
(Laser, Skogøy, Maybery & Wiegand-Grefe.
Implementierungs-Komponenten-Fragebogen.2019.
(in prep.)
|
Change from baseline of the study at 12- and 24-months follow-up
|
Implementation Satisfaction Scale (ISS)
Time Frame: Change from baseline of the study at 12- and 24-months follow-up
|
Measures from the employee's point of view how satisfied they are with the implementation process in their clinical centre.
(Laser, Skogøy, Maybery & Wiegand-Grefe.
Implementierungs-Komponenten-Fragebogen.2019.
(in prep.)
|
Change from baseline of the study at 12- and 24-months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sociodemografic information
Time Frame: At baseline of the study
|
Sociodemografic information of the employees, assessed from the perspective of the employees
|
At baseline of the study
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Silke Wiegand-Grefe, Prof. Dr., Universitätsklinikum Hamburg-Eppendorf
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Ci-Chimps
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Issue
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Hospices Civils de LyonNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
Stanford UniversityNot yet recruitingMental Health Issue
-
The Hong Kong Polytechnic UniversityRecruiting
-
Weill Medical College of Cornell UniversityDoris Duke Charitable FoundationNot yet recruiting
-
Yale UniversityEmpowerment to Heal - Uganda; Empower Through HealthRecruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
Dr. Nazanin AlaviWithdrawnMental Health IssueCanada
-
Northwestern UniversityWithdrawnMental Health IssueUnited States
Clinical Trials on Optimal pathways to care
-
University of MichiganWayne State University; The University of Texas at ArlingtonEnrolling by invitationViolence, Physical | Maltreatment, ChildUnited States
-
Laurie McLouthNational Cancer Institute (NCI)Recruiting
-
University Hospital, ToulouseCompleted
-
Radboud University Medical CenterWageningen University and Research; Movisie; Municipality of Meppel, the Netherlands and other collaboratorsCompletedPerceived Stress | Persistent PovertyNetherlands
-
Massachusetts General HospitalRecruitingRectal Cancer | Self EfficacyUnited States
-
Agenzia Regionale Sanitaria delle MarcheCompleted
-
Oslo University HospitalNorwegian University of Science and TechnologyCompleted
-
McGill UniversityNot yet recruitingCerebral Palsy | Amputation | Spinal Cord Injuries | Spina Bifida | Musculoskeletal Disorder | Juvenile ArthritisCanada
-
Case Comprehensive Cancer CenterAmerican Cancer Society, Inc.; Consumer Wellness Solutions; North Carolina Tobacco...Completed
-
University Hospital, ToulouseRecruiting